On Tuesday, Shares of Weight Watchers International, Inc. (NYSE:WTW), skyrocketed 31.11% to $18.25.
Weight Watchers International, has shown an uptrend of 157.77% in past 5 days with YTD performance of -26.53% and 3-month performance up 320.51%. Its latest closing price of $18.25 was 110.43% up from an average-price of 200 days while it maintained a distance from the SMA 50 at 182.83% and 161.41% compared with the SMA 20.
The stock was up 397.28% from the 52 week low and was -38.84% below the 52 week high.
Weight Watchers International, Inc. provides weight administration services worldwide. The company operates through North America, United Kingdom, Continental Europe, and Other segments. It offers a range of products and services comprising nutritional, exercise, and behavioral tools and approaches.
Shares of Intel Corporation (NASDAQ:INTC), declined -0.45% to $33.44, during its last trading session.
The year-to-date performance of the company stands at -5.74% with an advance of 4.37% in the last week and 17.85% in the previous three months.
Its most recent closing price of $33.44 was 34.46% up from the 52 week low and was -9.75% below the 52 week high. Its latest closing price was 6.80% up from an average-price of 200 days while it kept its distance from the SMA 50 at 13.09% and 7.92% compared with the SMA 20.
Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.
Finally, Pfizer Inc. (NYSE:PFE), ended its last trade with -1.45% loss, and closed at $34.
Pfizer, has YTD performance of 11.89%. The company has the market capitalization of $ 209.69B while its P/B ratio was 3.13. Institutional investors own 73.30% stake in the company while beta factor, which is used to measure riskiness of the security, was 0.94. Net profit margin of this company was 18.50% while its operating profit margin was 28.70%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
